Description
AttoDx is a biotechnology company developing applications for its proprietary Molecular Viability Testing (MVT). They partner with other companies and institutions to integrate this technology into various detection and diagnostic devices and instruments.
Team Members
James Davie
Founder, President, CEO
Paul Harris
VP Product Development
Jerry Cangelosi
Consulting Scientific Director, Associate Professor in Epidemiology and in Global Heath, University of Washington
Scott Meschke
Consulting Scientist
Harvey Hoyt
Consulting Medical Director
